Essayer OR - Gratuit
Why Aakash’s fundraise is now a proxy fight over Byju’s ownership
Mint New Delhi
|December 02, 2025
Beset Aakash Educational Services Ltd (AESL) thought a $250-crore rights issue would be its big reset after senior exits and a swing to losses in FY23.
The test-prep chain, once a profit engine for Byju’s, needs fresh capital to steady operations and fund growth.
The board opened the first $100-crore tranche to existing investors, including all major shareholders, such as Think & Learn Pvt. Ltd (TLPL), wiring their proportional amounts. However, AESL has now put TLPL’s $25-crore allotment on hold, stating that the funds do not comply with Foreign Exchange Management Act (Fema), the Companies Act, and External Commercial Borrowings (ECB) rules.
Mint explains what that dispute means:
How Aakash got here
The $250-crore rights issue follows a months-long legal tussle over Aakash’s plan to raise fresh capital via a shareholder offer. The fundraise was challenged by Byju’s, which acquired Aakash in a cash-and-stock deal worth about $950 million in April 2021, and one of its creditors.
Cette histoire est tirée de l'édition December 02, 2025 de Mint New Delhi.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint New Delhi
Mint New Delhi
Margin strain prompts wealth firms to expand
With a surge in affluent people, competition has intensified in the space
2 mins
December 10, 2025
Mint New Delhi
Govt picks fund managers for ₹1 tn deep-tech boost
DST has appointed BIRAC and TDB, and is set to add Sidbi and SBI Funds Management soon
2 mins
December 10, 2025
Mint New Delhi
Forgettable promos lead to ad fatigue for OTT viewers
Advertising on video-streaming services is increasingly resulting in viewer fatigue as platforms try to replace plateauing paid subscription revenue with ad money.
2 mins
December 10, 2025
Mint New Delhi
Novo moves HC to restrain Sun Pharma
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
1 mins
December 10, 2025
Mint New Delhi
Sibling disputes over residual assets: key principles explained
My father willed specific assets to my mother and me, and said any unspecified assets would go equally to my sister and me.
2 mins
December 10, 2025
Mint New Delhi
Healthcare to home repairs: how to plan for emergencies
More households are setting up dedicated reserve funds for unexpected, uninsured expenses
3 mins
December 10, 2025
Mint New Delhi
FIRs against Anil Ambani's son, group cos
The Central Bureau of Investigation (CBI) on Tuesday carried out searches at the residence of industrialist Anil Ambani’s son Jai Anmol Ambani in Mumbai after registering a case against him and a Reliance ADA Group company—Reliance Home Finance Ltd (RHFL) on a complaint of Union Bank of India, which alleged that a fraud of ₹2228 crore was committed against the bank.
1 mins
December 10, 2025
Mint New Delhi
Swiggy launches new share offering
Indian food delivery major Swiggy Ltd on Tuesday launched a new share offering for institutional investors to raise up to ₹10,000 crore ($1.1 billion), just a year after its market debut.
1 min
December 10, 2025
Mint New Delhi
PepsiCo agrees to pare its US lineup
PepsiCo Inc. reached an agreement with activist investor Elliott Investment Management to reduce its US product lineup by 20% and lower prices, while the company also pares its workforce.
1 min
December 10, 2025
Mint New Delhi
'Airlines' net profit likely $41 bn next yr'
Global airline trade body IATA said on Tuesday the airline sector would post record profits next year despite ongoing supply chain issues leading to slower aircraft deliveries and a delay in rolling out more fuel-efficient jets.
1 min
December 10, 2025
Listen
Translate
Change font size